학술논문
전자자료 공정이용 안내
우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.
공정이용 지침
- 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
- 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
- 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
- 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
- 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
- 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
- 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
- 상업적·영리적 목적으로 자료를 전송·복제·활용
- ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
- EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
- 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
- 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
- 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문'
에서 검색결과 53건 | 목록
1~20
Academic Journal
Knight, MA; Hernandez, D; Diede, SJ; Dauwerse, HG; Rafferty, I; van de Leemput, J; Forrest, SM; Gardner, RJM; Storey, E; van Ommen, G-JB; Tapscott, SJ; Fischbeck, KH; Singleton, AB
Hum Mol Genet
Academic Journal
Peterson, SE; Stellwagen, AE; Diede, SJ; Singer, MS; Haimberger, ZW; Johnson, CO; Tzoneva, M; Gottschling, DE
Academic Journal
Academic Journal
Academic Journal
Academic Journal
Hernáiz Driever P; Department of Pediatric Oncology/Hematology, Charité Universitaetsmedizin Berlin, Corporate Member of Freie Universitaet Berlin, Humboldt-Universitaet zu Berlin and Berlin Institute of Health, Berlin, Germany.; Kordes UR; Department of Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; Brecht IB; Pediatric Hematology and Oncology, Children's Hospital, Eberhard-Karls-Universitaet Tuebingen, Tübingen, Germany.; Saletti V; Department of Pediatric Neuroscience, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.; Fisher MJ; Division of Oncology, The Children's Hospital of Philadelphia and the University of Pennsylvania Perelman School of Medicine, Philadelphia, PA.; Doughton G; R&D Clinical Development, Alexion, AstraZeneca Rare Disease, Cambridge, United Kingdom.; Arefayene M; Clinical Pharmacology and Safety Sciences, Alexion, AstraZeneca Rare Disease, Boston, MA.; Rigazio A; Quantitative Science, Alexion, AstraZeneca Rare Disease, Barcelona, Spain.; Lluch N; R&D Clinical Development, Alexion, AstraZeneca Rare Disease, Barcelona, Spain.; Llorente N; Global Patient Safety, Alexion, AstraZeneca Rare Disease, Barcelona, Spain.; Diede SJ; Merck & Co, Inc, Rahway, NJ.; Salvador H; Department of Pediatric Oncology and Hematology, Sant Joan de Déu Barcelona Hospital, Barcelona, Spain.
Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE
Academic Journal
Arance A; Department of Medical Oncology, Hospital Clínic Barcelona and Translational Genomics and Targeted Therapies in Solid Tumours Research Group (IDIBAPS), Barcelona, Spain. Electronic address: amarance@clinic.cat.; Berciano-Guerrero MA; Department of Medical Oncology, Hospital Regional Universitario (HRU), Instituto de Investigaciones Biomédicas de Málaga-Plataforma BIONAND (IBIMA-BioNAND), Málaga, Spain.; Guo J; Department of Melanoma and Renal Cancer, Beijing University Cancer Hospital, Beijing, China.; Carlino MS; Melanoma Institute Australia, Westmead and Blacktown Hospitals, University of Sydney, Sydney, Australia.; Ascierto PA; Department of Skin Cancers, Cancer Immunotherapy and Development Therapeutics, Istituto Nazionale Tumori IRCCS Fondazione G Pascale, Naples, Italy.; Burotto M; Centro de Investigación Clínica Bradford Hill, Santiago, Chile.; Mortier L; Department of Dermatology, Université Lille, CHRU Lille, INSERM U1189, Lille, France.; Queirolo P; Division of Medical Oncology for Melanoma, Sarcoma, and Rare Tumors, European Institute of Oncology (IEO), IRCCS, Milan, Italy.; Chiarion-Sileni V; Melanoma Oncology Unit, Istituto Oncologico Veneto, IOV-IRCCS, Padova, Italy.; Schachter J; Oncology Division, Sheba Medical Center, Tel HaShomer Hospital, Ramat Gan, Israel.; Zhang X; Department of Medical Oncology, Sun Yat-sen University Cancer Centre, Guangzhou, China.; Martin-Liberal J; Instituto Català d'Oncologia (ICO)-Hospital Duran i Reynals, Barcelona, Spain.; Del Vecchio M; Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.; Okpara CE; Eisai Ltd., Hatfield, UK.; Dutcus C; Eisai Inc., Nutley, NJ, USA.; Zhang J; Merck & Co. Inc., Rahway, NJ, USA.; Diede SJ; Merck & Co. Inc., Rahway, NJ, USA.; Neff T; Merck & Co. Inc., Rahway, NJ, USA.; Long GV; Melanoma Institute Australia, University of Sydney, and Royal North Shore and Mater Hospitals, Sydney, Australia.
Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE
Academic Journal
Chen AP; Division of Cancer Treatment and Diagnosis, Developmental Therapeutics Clinic, National Cancer Institute, Bethesda, MD, USA. Electronic address: chenali@mail.nih.gov.; Coyne GO; Division of Cancer Treatment and Diagnosis, Developmental Therapeutics Clinic, National Cancer Institute, Bethesda, MD, USA; Mater Misericordiae University Hospital, Dublin, Ireland.; Wolters PL; Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.; Martin S; Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.; Farschtschi S; Department of Neurology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; Blanco I; Clinical Genetics Department, Hospital Germans Trias I Pujol, Barcelona, Spain.; Chen Z; Department of Neurosurgery/Neuro-oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Guangzhou, China.; Darrigo LG Jr; Department of Pediatrics, Ribeirão Preto Medical School, University of São Paulo, São Paulo, Brazil.; Eoli M; Department of Experimental Neuro-oncology, Fondazione IRCCS Besta, Milan, Italy.; Whittle JR; Department of Medical Oncology, Peter MacCallum Cancer Centre, Victoria, Australia.; Nishida Y; Department of Rehabilitation, Nagoya University Hospital, Nagoya, Japan.; Lamarca R; Alexion AstraZeneca Rare Disease, Barcelona, Spain.; de la Rosa Rodriguez R; Alexion AstraZeneca Rare Disease, MA, USA.; Adeyemi A; Alexion AstraZeneca Rare Disease, MA, USA.; Herrero I; Alexion AstraZeneca Rare Disease, Barcelona, Spain.; Llorente N; Alexion AstraZeneca Rare Disease, Barcelona, Spain.; Diede SJ; Merck, Rahway, NJ, USA.; Dombi E; Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.; Wolkenstein P; Department of Dermatology (CERENEF), Henri-Mondor Hospital, APHP, UPEC, Créteil, France; INSERM CIC 1430, Créteil, France.
Publisher: Elsevier Country of Publication: England NLM ID: 2985213R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-547X (Electronic) Linking ISSN: 01406736 NLM ISO Abbreviation: Lancet Subsets: MEDLINE
Academic Journal
Tan XL; Merck & Co., Inc., Rahway, NJ, United States.; Le A; Department of Epidemiology, Richard M. Fairbanks School of Public Health, Indiana University, Indianapolis, IN, United States.; Scherrer E; Merck & Co., Inc., Rahway, NJ, United States.; Seagen Inc., Bothell, WA, United States.; Tang H; Integrative Precision Health, LLC, Carmel, IN, United States.; Kiehl N; Department of Epidemiology, Richard M. Fairbanks School of Public Health, Indiana University, Indianapolis, IN, United States.; Han J; Integrative Precision Health, LLC, Carmel, IN, United States.; Jiang R; Merck & Co., Inc., Rahway, NJ, United States.; Diede SJ; Merck & Co., Inc., Rahway, NJ, United States.; Shui IM; Merck & Co., Inc., Rahway, NJ, United States.
Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE
Pembrolizumab in Chinese patients with advanced melanoma: 3-year follow-up of the KEYNOTE-151 study.
Academic Journal
Si L; Key Laboratory of Carcinogenesis and Translational Research, Ministry of Education/Beijing, Peking University Cancer Hospital and Institute, Beijing, China.; Zhang X; Sun Yat-sen University Cancer Centre, Guangzhou, China.; Shu Y; Jiangsu Province Hospital, Nanjing, China.; Pan H; Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China.; Wu D; The First Hospital of Jilin University, Changchun, China.; Liu J; The First Affiliated Hospital of Dalian Medical University, Dalian, China.; Mao L; Key Laboratory of Carcinogenesis and Translational Research, Ministry of Education/Beijing, Peking University Cancer Hospital and Institute, Beijing, China.; Wang X; Key Laboratory of Carcinogenesis and Translational Research, Ministry of Education/Beijing, Peking University Cancer Hospital and Institute, Beijing, China.; Wen X; Sun Yat-sen University Cancer Centre, Guangzhou, China.; Gu Y; Jiangsu Province Hospital, Nanjing, China.; Zhu L; Jiangsu Province Hospital, Nanjing, China.; Lan S; The First Hospital of Jilin University, Changchun, China.; Cai X; The First Affiliated Hospital of Dalian Medical University, Dalian, China.; Diede SJ; Merck and Co., Inc., Rahway, NJ, United States.; Dai H; MSD (China) Co., Ltd., Shanghai, China.; Niu C; MSD (China) Co., Ltd., Beijing, China.; Li J; MSD (China) Co., Ltd., Shanghai, China.; Guo J; Key Laboratory of Carcinogenesis and Translational Research, Ministry of Education/Beijing, Peking University Cancer Hospital and Institute, Beijing, China.
Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE
Academic Journal
Tan XL; Merck & Co., Inc., Rahway, NJ, United States.; Le A; Richard M. Fairbanks School of Public Health, Indiana University, Indianapolis, IN, United States.; Lam FC; Division of Neurosurgery, Huntington Hospital, Northwell Health, Huntington, NY, United States.; Scherrer E; Merck & Co., Inc., Rahway, NJ, United States.; Seagen Inc., Bothell, WA, United States.; Kerr RG; Division of Neurosurgery, Huntington Hospital, Northwell Health, Huntington, NY, United States.; Lau AC; Division of Neurosurgery, Huntington Hospital, Northwell Health, Huntington, NY, United States.; Han J; Integrative Precision Health, Limited Liability Company (LLC), Carmel, IN, United States.; Jiang R; Merck & Co., Inc., Rahway, NJ, United States.; Diede SJ; Merck & Co., Inc., Rahway, NJ, United States.; Shui IM; Merck & Co., Inc., Rahway, NJ, United States.
Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE
Academic Journal
Joseph RW; Department of Oncology (Medical), Mayo Clinic, Jacksonville, FL, USA.; Liu FX; Merck & Co., Philadelphia, PA, USA.; Shillington AC; EPI-Q, Inc., 915 Harger Rd, Suite 350, Oak Brook, IL, 60523, USA. alicia.shillington@epi-q.com.; Macahilig CP; Medical Data Analytics (MDA), Parsippany, NJ, USA.; Diede SJ; Merck & Co., North Wales, PA, USA.; Dave V; Medical Data Analytics (MDA), Parsippany, NJ, USA.; Harshaw Q; Merck & Co., Philadelphia, PA, USA.; Saretsky TL; Merck & Co., North Wales, PA, USA.; Pickard AS; Pharmacy Systems, Outcomes and Policy, College of Pharmacy, 833 South Wood Street, Chicago, IL, 60612, USA.
Publisher: Springer Netherlands Country of Publication: Netherlands NLM ID: 9210257 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-2649 (Electronic) Linking ISSN: 09629343 NLM ISO Abbreviation: Qual Life Res Subsets: MEDLINE
Academic Journal
Joseph RW; Department of Oncology (Medical), Mayo Clinic, Jacksonville, FL, USA.; Shillington AC; EPI-Q, Inc, Oak Brook, IL, USA.; Lee TA; Department of Pharmacy Systems, Outcomes, and Policy, College of Pharmacy, University of Illinois at Chicago, Chicago, IL, USA.; Macahilig CP; Medical Data Analytics (MDA), Parsippany, NJ, USA.; Diede SJ; Merck & Co, North Wales, PA, USA.; Dave V; Medical Data Analytics (MDA), Parsippany, NJ, USA.; Harshaw Q; EPI-Q, Inc, Oak Brook, IL, USA.; Scherrer E; Merck & Co, North Wales, PA, USA.; Liu FX; Merck & Co, North Wales, PA, USA.
Publisher: Taylor & Francis Country of Publication: England NLM ID: 9892255 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1941-837X (Electronic) Linking ISSN: 13696998 NLM ISO Abbreviation: J Med Econ Subsets: MEDLINE
Academic Journal
Chesney JA; UofL Health-Brown Cancer Center, University of Louisville, Louisville, KY.; Ribas A; Jonsson Comprehensive Cancer Center at the University of California Los Angeles, Los Angeles, CA.; Long GV; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia.; Royal North Shore and Mater Hospitals, Sydney, NSW, Australia.; Kirkwood JM; UPMC Hillman Cancer Center, Pittsburgh, PA.; Dummer R; University Hospital of Zurich, Zurich, Switzerland.; Puzanov I; Roswell Park Comprehensive Cancer Center, Buffalo, NY.; Hoeller C; Department of Dermatology, Medical University of Vienna, Vienna, Austria.; Gajewski TF; University of Chicago Medical Center, Chicago, IL.; Gutzmer R; Medizinische Hochschule Hannover, Hannover, Germany.; Mühlenkreiskliniken Minden, Ruhr University Bochum, Bochum, Germany.; Rutkowski P; Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.; Demidov L; N.N. Blokhin Russian Cancer Research Center, Moscow, Russia.; Arenberger P; University Hospital Královské Vinohrady, Prague, Czech Republic.; Shin SJ; Division of Oncology, Yonsei University College of Medicine, Seoul, Korea.; Ferrucci PF; Biotherapy of Tumors Unit, Department of Experimental Oncology, European Institute of Oncology, IRCCS, Milan, Italy.; Haydon A; Department of Medical Oncology, Alfred Hospital, Melbourne, Australia.; Hyngstrom J; Huntsman Cancer Institute, University of Utah Health, Salt Lake City, UT.; van Thienen JV; Netherlands Cancer Institute, Amsterdam, the Netherlands.; Haferkamp S; Department of Dermatology, University Hospital Regensburg, Regensburg, Germany.; Guilera JM; Department of Dermatology, Barcelona University, Barcelona, IDIBAPS, CIBER de Enfermedades Raras ISCIII, Madrid, Spain.; Rapoport BL; The Medical Oncology Centre of Rosebank, Johannesburg, South Africa.; Department of Immunology, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa.; VanderWalde A; Department of Hematology/Oncology, West Cancer Center & Research Institute, Memphis, TN.; Diede SJ; Merck & Co, Inc, Kenilworth, NJ.; Anderson JR; Merck & Co, Inc, Kenilworth, NJ.; Treichel S; Amgen Inc, South San Francisco, CA.; Chan EL; Amgen Inc, Thousand Oaks, CA.; Bhatta S; Amgen Inc, Thousand Oaks, CA.; Gansert J; Amgen Inc, Thousand Oaks, CA.; Hodi FS; Dana-Farber Cancer Institute, Boston, MA.; Gogas H; National and Kapodistrian University of Athens, Athens, Greece.
Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE
Academic Journal
Arance A; Hospital Clinic Barcelona and IDIBAPS, Barcelona, Spain.; de la Cruz-Merino L; Hospital Universitario Virgen Macarena, Seville, Spain.; Petrella TM; Sunnybrook Health Sciences Centre, Toronto, ON, Canada.; Jamal R; Centre Hospitalier de l'Université de Montréal (CHUM), Centre de recherche du CHUM, Montréal, QC, Canada.; Ny L; University of Gothenburg and Sahlgrenska University Hospital, Gothenburg, Sweden.; Carneiro A; Skåne University Hospital Comprehensive Cancer Center and Lund University, Lund, Sweden.; Berrocal A; Hospital General Universitario de Valencia, Valencia, Spain.; Márquez-Rodas I; Hospital General Universitario Gregorio Marañón and CIBERONC, Madrid, Spain.; Spreafico A; Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, ON, Canada.; Atkinson V; Princess Alexandra Hospital, University of Queensland, Brisbane, QLD, Australia.; Costa Svedman F; Karolinska University Hospital, Stockholm, Sweden.; Mant A; Eastern Health, Monash University, Melbourne, VIC, Australia.; Khattak MA; Fiona Stanley Hospital, Murdoch and Edith Cowan University, Perth, WA, Australia.; Mihalcioiu C; Royal Victoria Hospital, McGill University, Montréal, QC, Canada.; Jang S; Inova Schar Cancer Institute, Fairfax, VA.; Cowey CL; Texas Oncology-Baylor Charles A. Sammons Cancer Center, Dallas, TX.; Smith AD; Eisai Ltd, Hatfield, United Kingdom.; Hawk N; Eisai Inc, Nutley, NJ.; Chen K; Merck & Co, Inc, Rahway, NJ.; Diede SJ; Merck & Co, Inc, Rahway, NJ.; Krepler C; Merck & Co, Inc, Rahway, NJ.; Long GV; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia.; Faculty of Medicine & Health, The University of Sydney, Sydney, NSW, Australia.; Charles Perkins Centre, The University of Sydney, Sydney, NSW, Australia.; Royal North Shore and Mater Hospitals, Sydney, NSW, Australia.
Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE
Academic Journal
Tan XL; Merck & Co., Inc., Rahway, NJ 07065, USA.; Le A; Richard M. Fairbanks School of Public Health, Indiana University, Indianapolis, IN 46202, USA.; Tang H; Integrative Precision Health, LLC, Carmel, IN 46032, USA.; Brown M; Richard M. Fairbanks School of Public Health, Indiana University, Indianapolis, IN 46202, USA.; Scherrer E; Merck & Co., Inc., Rahway, NJ 07065, USA.; Seagen Inc., Bothell, WA 98021, USA.; Han J; Integrative Precision Health, LLC, Carmel, IN 46032, USA.; Jiang R; Merck & Co., Inc., Rahway, NJ 07065, USA.; Diede SJ; Merck & Co., Inc., Rahway, NJ 07065, USA.; Shui IM; Merck & Co., Inc., Rahway, NJ 07065, USA.
Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE
Academic Journal
Pinto N; Seattle Children's Hospital, University of Washington, Seattle, Washington.; DuBois SG; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, Massachusetts.; Marachelian A; Children's Hospital Los Angeles, University of Southern California Keck School of Medicine, Los Angeles, California.; Diede SJ; Global Clinical Development-Oncology, Merck Research Laboratories, North Wales, Pennsylvania.; Taraseviciute A; Seattle Children's Hospital, University of Washington, Seattle, Washington.; Glade Bender JL; Division of Pediatric Hematology, Oncology, and Stem Cell Transplantation, Columbia University Medical Center, New York City, New York.; Tsao-Wei D; Department of Preventative Medicine, University of Southern California, Los Angeles, California.; Groshen SG; Department of Preventative Medicine, University of Southern California, Los Angeles, California.; Reid JM; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, Minnesota.; Haas-Kogan DA; Department of Radiation Oncology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.; Reynolds CP; Cancer Center and Cell Biology, Texas Tech University Health Sciences Center School of Medicine, Lubbock, Texas.; Kang MH; Cancer Center and Cell Biology, Texas Tech University Health Sciences Center School of Medicine, Lubbock, Texas.; Irwin MS; Division of Haematology/Oncology, The Hospital for Sick Children, University of Toronto, Toronto, Canada.; Macy ME; Pediatric Hematology/Oncology/Bone Marrow Transplant, University of Colorado Anschutz Medical Campus, Aurora, Colorado.; Villablanca JG; Children's Hospital Los Angeles, University of Southern California Keck School of Medicine, Los Angeles, California.; Matthay KK; UCSF Benioff Children's Hospital, University of California, San Francisco, California.; UCSF School of Medicine, University of California, San Francisco, California.; Park JR; Seattle Children's Hospital, University of Washington, Seattle, Washington.
Publisher: John Wiley Country of Publication: United States NLM ID: 101186624 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1545-5017 (Electronic) Linking ISSN: 15455009 NLM ISO Abbreviation: Pediatr Blood Cancer Subsets: MEDLINE
Academic Journal
Luke JJ; UPMC Hillman Cancer Center, Pittsburgh, PA, USA. Electronic address: lukejj@upmc.edu.; Rutkowski P; Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.; Queirolo P; Istituto Europeo di Oncologia - IRCCS, Milano; Ospedale San Martino IRCCS, Genova, Italy.; Del Vecchio M; Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy.; Mackiewicz J; Poznan University of Medical Sciences, Poznan, Poland; Greater Poland Cancer Center, Poznan, Poland.; Chiarion-Sileni V; Istituto Oncologico Veneto, IOV-IRCCS, Padova, Italy.; de la Cruz Merino L; Clinical Oncology Department, Hospital Universitario Virgen Macarena, Sevilla, Spain; Medicine Department, Universidad de Sevilla, Sevilla, Spain.; Khattak MA; Fiona Stanley Hospital & Edith Cowan University, Perth, WA, Australia.; Schadendorf D; University Hospital Essen and German Cancer Consortium Partner Site, Essen, Germany.; Long GV; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia; Charles Perkins Center, The University of Sydney, Sydney, NSW, Australia; Royal North Shore and Mater Hospitals, Sydney, NSW, Australia.; Ascierto PA; Istituto Nazionale Tumori IRCCS Fondazione Pascale, Naples, Italy.; Mandala M; University of Perugia, Perugia, Italy; Ospedale Papa Giovanni XXIII, Bergamo, Italy.; De Galitiis F; Dermopathic Institute of the Immaculate IDI-IRCCS, Rome, Italy.; Haydon A; Alfred Hospital, Monash University, Melbourne, VIC, Australia.; Dummer R; University Hospital Zürich, University of Zurich, Skin Cancer Center, Zurich, Switzerland.; Grob JJ; AP-HM Hospital, Aix-Marseille University, Marseille, France.; Robert C; Institut Gustave Roussy, Villejuif, France; Paris-Saclay University, Villejuif, France.; Carlino MS; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia; Westmead and Blacktown Hospitals, Sydney, NSW, Australia.; Mohr P; Elbe Kliniken Buxtehude, Buxtehude, Germany.; Poklepovic A; VCU Massey Cancer Center, Richmond, VA, USA.; Sondak VK; H Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.; Scolyer RA; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia; Charles Perkins Center, The University of Sydney, Sydney, NSW, Australia; Royal Prince Alfred Hospital Sydney, NSW, Australia; NSW Health Pathology, Sydney, NSW, Australia.; Kirkwood JM; UPMC Hillman Cancer Center, Pittsburgh, PA, USA.; Chen K; Merck & Co, Inc., Kenilworth, NJ, USA.; Diede SJ; Merck & Co, Inc., Kenilworth, NJ, USA.; Ahsan S; Merck & Co, Inc., Kenilworth, NJ, USA.; Ibrahim N; Merck & Co, Inc., Kenilworth, NJ, USA.; Eggermont AMM; University Medical Center Utrecht, Utrecht, Netherlands; Princess Máxima Center, Utrecht, Netherlands; Comprehensive Cancer Center Munich, Munich, Germany.
Publisher: Elsevier Country of Publication: England NLM ID: 2985213R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-547X (Electronic) Linking ISSN: 01406736 NLM ISO Abbreviation: Lancet Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[Author] Diede SJ
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어